ENTERPRISE PRODUCTS PARTNERS L.P. Quarterly Deferred Federal Income Tax Expense (Benefit) in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Enterprise Products Partners L.P. quarterly/annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from Q1 2019 to Q2 2024.
  • Enterprise Products Partners L.P. Deferred Federal Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $4M.
  • Enterprise Products Partners L.P. Deferred Federal Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$5M, a 267% decline year-over-year.
  • Enterprise Products Partners L.P. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was -$17M, a 185% decline from 2022.
  • Enterprise Products Partners L.P. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was $20M, a 25.9% decline from 2021.
  • Enterprise Products Partners L.P. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was $27M.
Deferred Federal Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5M $4M +$15M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$20M $4M -$3M -42.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$17M -$17M -$18M -1800% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $1M $4M -$2M -33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3M -$11M -$17M -283% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $20M $7M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $20M $1M -$7M -87.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27M $6M -$1M -14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $28M $6M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $28M $7M +$1M +16.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $27M $8M +$4.9M +158% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $22.1M $7M +$25.7M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$3.6M $6M -$40.4M -87.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $36.8M $6M +$179M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$142M $3.1M +$1.7M +121% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$144M -$18.7M -$19M -6333% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$125M $46.4M +$46.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$66.1M -$173M -$173M -172700% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2020 -$67.8M -$67.7M -67700% Mar 1, 2020 Mar 5, 2020 10-Q 2021-08-09
Q4 2019 $1.6M $1.4M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $300K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$100K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.